Business
Novavax to Participate in the BofA Securities 2023 Health Care Conference
GAITHERSBURG, Md., May 4, 2023 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its novel Matrix-M™
About this update from Novavax, Inc.
[{"type":"text","content":"GAITHERSBURG, Md., May 4, 2023 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its novel Matrix-M™ adjuvant, today announced that it will participate in the BofA Securities 2023 Health Care Conference.\nConference Details:\nFireside Chat\nDate:\nThursday, May 11, 2023\nTime:\n10:00 – 10:30 a.m. Pacific Daylight Time (PDT)\nLocation:\nEncore Hotel in Las Vegas, Nevada\nModerator:\nAlec Stranahan, Ph.D., Equity Research Analyst – Biotechnology\nNovavax participants:\nJohn C. Jacobs, President and Chief Executive Officer and\nFilip Dubovsky, M.D., President, Research & Development\nConference\nEvent:\nInvestor Meetings\nDate:\nWednesday, May 10, 2023 - Thursday, May 11, 2023\nRecordingsA replay of the recorded fireside session will be available through the Events & presentations page of the Company's website at ir.novavax.com for 90 days from the date of the conference.\nAbout NovavaxNovavax, Inc. (Nasdaq: NVAX) promotes improved health by discovering, developing and commercializing innovative vaccines to protect against serious infectious diseases. Novavax, a global company based in Gaithersburg, Md., U.S., offers a differentiated vaccine platform that combines a recombinant protein approach, innovative nanoparticle technology and Novavax's patented Matrix-M adjuvant to enhance the immune response. Focused on the world's most urgent health challenges, Novavax is currently evaluating vaccines for COVID-19, influenza, and COVID-19 and influenza combined.\nPlease visit novavax.com and LinkedIn for more information.\nContacts: InvestorsErika Schultz | [email protected]\nMediaAli Chartan or Giovanna Chandler | [email protected]\n\n \n\n\n\n View original content to download multimedia:https://www.prnewswire.com/news-releases/novavax-to-participate-in-the-bofa-securities-2023-health-care-conference-301816524.html\nSOURCE Novavax, Inc.","length":12153,"tagName":"div"}]